Home
Bivalirudin
Breastfeeding
Bivalirudin use while Breastfeeding
Medically reviewed by Drugs.com. Last updated on Feb 12, 2025.
Drugs containing Bivalirudin: Angiomax, Angiomax RTU
Bivalirudin Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the use of bivalirudin during breastfeeding. Because the drug is absorbed orally, an alternate drug is preferred.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Bivalirudin
CAS Registry Number
128270-60-0
Drug Class
Breast Feeding
Lactation
Milk, Human
Anticoagulants
Antithrombins
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
More about bivalirudin
Patient resources
Other brands Angiomax
Professional resources
Other brands Angiomax
Related treatment guides
Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medical Disclaimer